NeuroPace (NPCE) Current Deferred Revenue (2020 - 2026)

NeuroPace's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 85.71% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was $100000.0, a 85.71% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 83.33% from the prior year.
• Current Deferred Revenue steadied at $100000.0 in Q1 2026 per NPCE's latest filing, from $100000.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.1 million in Q4 2023 and bottomed at $100000.0 in Q4 2025.
• The 4-year median for Current Deferred Revenue is $700000.0 (2025), against an average of $631800.0.
• Across the five-year window, Current Deferred Revenue fell 12.5% in 2025 and sank 85.71% in 2026, its largest moves.
• Year by year, Current Deferred Revenue stood at $1.1 million in 2023, then plunged by 45.45% to $600000.0 in 2024, then tumbled by 83.33% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
• Per Business Quant, the three latest NPCE Current Deferred Revenue figures stand at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $600000.0 (Q3 2025).